| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |